+8,077.9%
AMD vs GSK
+102.9%
+7,975.0%
-65.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +14.7% | +1.8% | +12.9% | +14.3% |
| 7D | +6.5% | +5.2% | +1.3% | +5.4% |
| 30D | -15.3% | +10.2% | -25.4% | -17.3% |
| 3M | +9.7% | -0.9% | +10.6% | +9.6% |
| 6M | +13.2% | +3.5% | +9.7% | +11.0% |
| YTD | +140.6% | +7.2% | +133.3% | +130.2% |
| 1Y | +111.2% | +12.0% | +99.2% | +98.9% |
| 3Y | +334.4% | +67.3% | +267.1% | +236.9% |
| 5Y | +268.3% | +45.3% | +223.1% | +198.3% |
| 10Y | +8,077.9% | +101.8% | +7,976.2% | +5,856.9% |
| All | +8,077.9% | +102.9% | +7,975.0% | +5,856.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling